Drug companies are not able to see a physician’s prescribing habits in New Hampshire, according to Tuesday’s ruling in a federal appeals court.
Reps often would have a detailed dossier on the doctor prior to any interaction, and can tailor their pitch and approach based on prescribing trends. It would be interesting to see how they do without that information.
Thanks to the WSJ Health Blog for picking up my Tweet on the subject.
topics: new hampshire, drug reps
